In this paper, we examine trends in provider fees charged, government expenditure on private out-of-hospital medical services, and out of pocket costs following policy changes intended to reduce government expenditure. We examine the experience of a high-need patient group: people diagnosed with...

The Extended Medicare Safety Net (EMSN) in Australia was designed to provide financial assistance to patients with high out-of-pocket (OOP) costs for medical treatment. The EMSN works on a calendar year basis. Once a patient incurs a specified amount of OOP costs, the EMSN provides additional...

Major health shocks can have far-reaching consequences on the welfare of an individual's support and emotional network. This paper investigates both long-term and short-term spillovers of a major non-communicable health shock, namely a cancer diagnosis (CD), on the health and well-being of an...

Emerging strands of research have examined the family spillover effects of health shocks, usually focusing on labour market outcomes. However, the results have been inconclusive and there is only little evidence on the longer term consequences of health shocks or the mechanisms behind the...

Major health shocks can have far-reaching consequences on the welfare of an individual's support and emotional network. This paper investigates both long-term and short-term spillovers of a major non-communicable health shock, namely a cancer diagnosis (CD), on the health and well- being of an...

Research on the family spillover effects of health shocks, which has focused mainly on labor market outcomes, has yielded inconclusive results, with limited insight into long-term consequences or underlying mechanisms. We analyze the short- and long-term impacts of cancer on the unaffected...

Research on the family spillover effects of health shocks, which has focused mainly on labor market outcomes, has yielded inconclusive results, with limited insight into long-term consequences or underlying mechanisms. We analyze the short- and long-term impacts of cancer on the unaffected...

Different types of mathematical models can be used to forecast the development of diseases as well as associated costs and analyse the cost-effectiveness of interventions. The set of models available to assess these parameters, reach from simple independent equations to highly complex...

Background Cancer patients face a costly trade-off between medical care and basic necessities including food. This study aims to explore whether catastrophic health expenditures lead to food insecurity among older cancer survivors in the US. Methods Longitudinal study of individuals aged 50 or...

Objectives To conduct pooled estimates and comparative evaluations of safety and efficacy, alongside cost-effectiveness and value-based pricing analyses, for systemic treatments recommended by the National Comprehensive Cancer Network in refractory colorectal cancer. Methods A comprehensive...

Background Within Finland's breast cancer screening program, all women aged 50-69 are invited to biennial screening. Current European guidelines recommend screening in ages 45-49 and 70-74 conditional upon, inter alia, demonstrated context-specific cost-effectiveness. This study aims to...

Four years after its adoption, Europe's Beating Cancer Plan is making a positive impact on people's lives by boosting collaboration and forging a path towards better prevention, early detection, treatment and care as well as improving the quality of life of cancer patients and survivors.

Soil pollution is a significant environmental and health concern in Europe, with potential links to cancer incidence. The Exploratory Research project "Understanding the links between SOil pollution and CancEr" (SOLACE)" aimed to investigate the complex relationships between soil properties,...

The number of people living with cancer in the EU is increasing due to the ageing population and lower cancer mortality. Large differences in cancer incidence and mortality persist across countries, with wide disparities between high- and low-income countries, higher rates among men than women...

By enhancing breast, cervical, and colorectal cancer screening, and introducing new programs for lung, prostate, and gastric cancers, the project supports Europe's Beating Cancer Plan through AI, personalized approaches, and robust quality assurance.

EUnetCCC establishes a Europe-wide network of certified Comprehensive Cancer Centres, integrating cutting-edge research with high-quality cancer care. The initiative aims to reduce disparities, foster collaboration, and ensure equitable access to innovative treatments for patients across Europe...

CAT-ClinART will establish a regional structure for Radiotherapy clinical audits in Catalonia. The project includes the implementation of a specialized training course, the development of the methodology and essential infrastructure to support clinical audits and a pilot test in all radiotherapy...

DESIPOC is the first virtual platform of its kind targeting mental health challenges for all: patients, families, carers and healthcare professionals contributing to holistic care in the European health systems.

ALTHEA will develop a web-based platform to facilitate the screening of mental health issues among cancer patients and their families, while supporting patients and healthcare providers in accessing up-to-date educational materials and promoting the delivery of tailored psychological support.

MELODIC aims to promote mental health and well-being of young adults with cancer diagnosis, and their family/caregivers by improving screening, early detection, and efficient and person-centered management of mental health needs during the first year after their cancer diagnosis.

Patients will play a vital role in Health Technology Assessments across the EU when the HTA Regulation ((EU) 2021/2282) comes into force in 2025. Over the past 12 years, The European Patients' Academy on Therapeutic Innovation (EUPATI) has become a key multistakeholder actor for patient...

The number of people living with cancer in the EU is increasing due to the ageing population and lower cancer mortality. Large differences in cancer incidence and mortality persist across countries, with wide disparities between high- and low-income countries, higher rates among men than women...

The European Agency for Safety and Health at Work (EU-OSHA) conducted the Workers' Exposure Survey on cancer risk factors in Europe (WES), which estimates exposure to cancer risk factors among European workers, including in the health and social care (HeSCare) sector, which is one of the largest...

In 2008 the European Parliament and Council developed a strategy to support Member States in reducing the cancer burden, with a particular focus on the most frequent cancers. This was followed by the European Commission's Beating Cancer Plan, and the launch of the EC Initiative on Cervical...

In 2008 the European Parliament and Council developed a strategy to support Member States in reducing the cancer burden, with a particular focus on the most frequent cancers. This was followed by the European Commission's Beating Cancer Plan, and the launch of the EC Initiative on Cervical...

Why an EU Mission on cancer? Because cancer affects us all, creating a ripple effect that burdens families, societies, and economies. Every year the EU sees: 2.7 million new cancer diagnoses; 1.3 million lives lost; €200 billion economic toll. What's more, the annual number of diagnoses in...

Skin cancer is the abnormal development of cells on the surface of the skin and is one of the most fatal diseases in humans. It usually appears in locations that are exposed to the sun, but can also appear in areas that are not regularly exposed to the sun. Due to the striking similarities...

Objectives The aim of this study is to analyse the trends in technology appraisals for non-small cell lung cancer (NSCLC) treatments performed by the National Institute for Health and Care Excellence (NICE) over the last ten years. Methods A systematic search was conducted for single technology...

Natural products have always played an important part in cancer treatment. These chemicals are generally obtained from plants and microbes, which are significant sources of bioactive molecules with strong anticancer effects. Plant-derived anticancer drugs include Cisplatin, Taxanes, Gemcitabine,...

Europe's Beating Cancer Plan (EBCP), adopted in February 2021, proposes actions across the four pillars of the cancer pathway, i.e. prevention, early detection, diagnosis and treatment, and quality of life of cancer patients and survivors, and three cross-cutting themes, i.e. research and...

In this annex we include the four case studies conducted for each of the four pillars of the EBCP. Each case study is based on a selection of project grants, procurement contracts and Joint Actions (JA) related to cancer funded under the EU4Health Programme. The case studies cover projects...

The European Commission Initiative on Breast Cancer offers a person-centred quality assurance scheme (the European QA scheme) alongside the European evidence-based guidelines. This initiative aims to support healthcare providers and screening programme organisers, as well as policymakers and...

The European Commission Initiative on Breast Cancer offers a person-centred quality assurance scheme (the European QA scheme) alongside the European evidence-based guidelines. This initiative aims to support healthcare providers and screening programme organisers, as well as policymakers and...

The new NoEs will provide services to the whole European oncology community, including clinical practice guidelines and recommendations; quality of care criteria; health care and economic models; educational support; research promotion; support to patient advocates; support to political advocacy,...

This report documents the process and findings of a horizon scanning exercise, part of a series under the FUTURINNOV (FUTURe-oriented detection and assessment of emerging technologies and break-through INNOVation) project, a collaboration between the European Innovation Council (EIC) and the...